Notch2 negatively regulates myofibroblastic differentiation of myoblasts

Journal of Cellular Physiology

Volumn 210, Issue 2, 2007, Pages 358-369

  Ono, Yusuke ^a   Sensui, Hiroomi ^b   Okutsu, Saeko ^a   Nagatomi, Ryoichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b PHYSICAL FITNESS RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CELL STRAIN C2C12; CONTROLLED STUDY; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; KNOCKOUT GENE; MALE; MESENCHYMAL STEM CELL; MOUSE; MYOBLAST; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS REGULATION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; RNA INTERFERENCE; SKELETAL MUSCLE;

ACTINS; ANIMALS; CELL DIFFERENTIATION; CELL LINE; COLLAGEN TYPE I; DOWN-REGULATION; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE; MICE, INBRED C57BL; MUSCULAR DISEASES; MYOBLASTS, SKELETAL; RECEPTOR, NOTCH2; RECEPTORS, NOTCH; REGENERATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 33845670433     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20838     Document Type: Article

References (39)

1. Bernasconi P, Torchiana E, Confalonieri P, Brugnoni R, Barresi R, Mora M, Cornelio F, Morandi L, Mantegazza R. 1995. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest 96(2):1137-1144.
2. Bernasconi P, Di Blasi C, Mora M, Morandi L, Galbiati S, Confalonieri P, Cornelio F, Mantegazza R. 1999. Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies. Neuromuscul Disord 9(1):28-33.
3. Bjorkerud S. 1991. Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb 11(4):892-902.
4. Blom IE, Goldschmeding R, Leask A. 2002. Gene regulation of connective tissue growth factor: New targets for antifibrotic therapy? Matrix Biol 21(6):473-482.
5. Charge SB, Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84(1):209-238.
6. Darby I, Skalli O, Gabbiani G. 1990. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 63(1):21-29.
7. Davison SP, McCaffrey TV, Porter MN, Manders E. 1999. Improved nerve regeneration with neutralization of transforming growth factor-beta1. Laryngoscope 109(4):631-635.
8. Deaton RA, Su C, Valencia TG, Grant SR. 2005. Transforming growth factor-beta1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J Biol Chem 280(35):31172-31181.
9. Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, Krebs LT, Klonjkowski B, Berrou E, Mericskay M, Li Z, Tournier-Lasserve E, Gridley T, Joutel A. 2004. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 18(22):2730-2735.
10. Grainger DJ, Metcalfe JC, Grace AA, Mosedale DE. 1998. Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo. J Cell Sci 111(Pt 19):2977-2988.
11. Hamada Y, Kadokawa Y, Okabe M, Ikawa M, Coleman JR, Tsujimoto Y. 1999. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development 126(15):3415-3424.
12. Hansson EM, Lendahl U, Chapman G. 2004. Notch signaling in development and disease. Semin Cancer Biol 14(5):320-328.
13. Hautmann MB, Madsen CS, Owens GK. 1997. A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 272(16):10948-10956.
14. Hsieh JJ, Nofziger DE, Weinmaster G, Hayward SD. 1997. Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation. J Virol 71(3):1938-1945.
15. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. 1993. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4(6):637-645.
16. Ishitobi M, Haginoya K, Zhao Y, Ohnuma A, Minato J, Yanagisawa T, Tanabu M, Kikuchi M, Iinuma K. 2000. Elevated plasma levels of transforming growth factor betal in patients with muscular dystrophy. Neuroreport 11(18):4033-4035.
17. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. 1996. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383(6602):707-710.
18. Kirschenlohr HL, Metcalfe JC, Weissberg PL, Grainger DJ. 1993. Adult human aortic smooth muscle cells in culture produce active TGF-beta. Am J Physiol 265(2 Pt 1):C571-C576.
19. Kothapalli D, Frazier KS, Welply A, Segarini PR, Grotendorst GR. 1997. Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ 8(1):61-68.
20. Leask A, Abraham DJ. 2004. TGF-beta signaling and the fibrotic response. FASEB J 18(7):816-827.
21. Li Y, Huard J. 2002. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 161(3):895-907.
22. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, Cummins J, Huard J. 2004. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: A key event in muscle fibrogenesis. Am J Pathol 164(3):1007-1019.
23. Lindsell CE, Boulter J, diSibio G, Gossler A, Weinmaster G. 1996. Expression patterns of Jagged, Delta1, Notch1, Notch2, and Notch3 genes identify ligand-receptor pairs that may function in neural development. Mol Cell Neurosci 8(1):14-27.
24. Loomes KM, Taichman DB, Glover CL, Williams PT, Markowitz JE, Piccoli DA, Baldwin HS, Oakey RJ. 2002. Characterization of Notch receptor expression in the developing mammalian heart and liver. Am J Med Genet 112(2): 181-189.
25. Mayer DC, Leinwand LA. 1997. Sarcomeric gene expression and contractility in myofibroblasts. J Cell Biol 139(6):1477-1484.
26. Mitsiadis TA, Romeas A, Lendahl U, Sharpe PT, Farges JC. 2003. Notch2 protein distribution in human teeth under normal and pathological conditions. Exp Cell Res 282(2):101-109.
27. Nofziger D, Miyamoto A, Lyons KM, Weinmaster G. 1999. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development 126(8):1689-1702.
28. Ogata I, Saez CG, Greenwel P, Ponce Mde L, Geerts A, Leinwand LA, Rojkind M. 1993. Rat liver fat-storing cell lines express sarcomeric myosin heavy chain mRNA and protein. Cell Motil Cytoskeleton 26(2):125-132.
29. Ono Y, Sensui H, Sakamoto Y, Nagatomi R. 2006. Knockdown of hypoxia-inducible factor-1alpha by siRNA inhibits C2C12 myoblast differentiation. J Cell Biochem 98(3):642-649.
30. Owens GK, Geisterfer AA, Yang YW, Komoriya A. 1988. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol 107(2):771-780.
31. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. 1999. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277(1 Pt 1):C1-C9.
32. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75(7): 1351-1359.
33. Schaart G, Pieper FR, Kuijpers HJ, Bloemendal H, Ramaekers FC. 1991. Baby hamster kidney (BHK-21/C13) cells can express striated muscle type proteins. Differentiation 46(2):105-115.
34. Shimizu K, Chiba S, Saito T, Kumano K, Hamada Y, Hirai H. 2002. Functional diversity among Notch1, Notch2, and Notch3 receptors. Biochem Biophys Res Commun 291(4):775-779.
35. Stauber WT, Smith CA, Miller GR, Stauber FD. 2000. Recovery from 6 weeks of repeated strain injury to rat soleus muscles. Muscle Nerve 23(12):1819-1825.
36. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. 2002. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3(5):349-363.
37. Wagers AJ, Conboy IM. 2005. Cellular and molecular signatures of muscle regeneration: Current concepts and controversies in adult myogenesis. Cell 122(5):659-667.
38. Yamazaki M, Minota S, Sakurai H, Miyazono K, Yamada A, Kanazawa I, Kawai M. 1994. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am J Pathol 144(2):221-226.
39. Zhou G, Li C, Cai L. 2004. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol 165(6):2033-2043.